Keyphrases
Clinical Outcomes
100%
Genetic Variants
100%
Epithelial-mesenchymal Transition
100%
Localized Prostate Cancer
100%
Single nucleotide Polymorphism
100%
Confidence Interval
85%
Biochemical Recurrence
85%
Hazard Ratio
57%
Epithelial-mesenchymal Transition Pathway
42%
Disease Reclassification
42%
Odds Ratio
28%
Aggressiveness
28%
Active Surveillance
28%
Recurrence Hazard
28%
Reclassification
28%
Prostate Cancer
14%
Risk Estimation
14%
Prostate Cancer Patients
14%
Recurrence Risk
14%
Patient Cohort
14%
Cumulative Effects
14%
Risk Classification
14%
CtBP
14%
Prostate Cancer Aggressiveness
14%
Agricultural and Biological Sciences
Genetic Divergence
100%
Single Nucleotide Polymorphism
100%
Epithelial-Mesenchymal Transition
100%
Confidence Interval
85%
Odds Ratio
28%
Endpoints
28%
Risk Estimate
14%
C-Terminus
14%
Binding Protein
14%
Biochemistry, Genetics and Molecular Biology
Genetic Divergence
100%
Mesenchymal-Epithelial Transition
100%
Single-Nucleotide Polymorphism
100%
Clebopride
42%
C-Terminus
14%
Binding Protein
14%
Neuroscience
Single-Nucleotide Polymorphism
100%
Epithelial Mesenchymal Transition
100%
Prostate
71%
Clebopride
42%
C-Terminus
14%
Protein Binding
14%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Biochemical Recurrence
100%
Diseases
50%
Clebopride
50%
Recurrence Risk
16%
Binding Protein
16%